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ITV coverage was then evaluated by comparing the volume 
covered by the prescription isodose on full bladder CT-
planning and CT-control. 
Patients were asked to have full bladder but they did not 
follow specific recommendation for rectum. 
We investigated the correlation of 3D vector and loss of 
dosimetric coverage with bladder volume, rectal volume, 
maximum rectal diameter and AP rectal diameter at tip of 
coccyx level. 
Results: The ITV displacements turned out to be (mean ± SD) 
0.17 ± 0.12cm (range 0.01-0.50) in Left-Right, 0.41 ± 0.31cm 
(0.03-1.26) in anteroposterior and 0.35 ± 0.28cm (0.00-0.93) 
in craniocaudal direction. Mean 3D vector was 0.64 ± 0.32cm 
(0.09-1.30). 
All patients with 3D vector<0.7 cm (59.3%) showed a loss of 
coverage less than 10%. The rest of patients had a 3D 
vector>0.7 cm, but only 15% (4/27) had a loss of coverage 
higher than 10% (range 16.4-20.2%). 
We found a correlation between the 3D vector and the loss of 
coverage (Pearson correlation 0,51; p=0,007). 
We did not find any significant correlation of different rectal 
and bladder parameters with the 3D vector and loss of 
dosimetric coverage.  
Conclusions: Although vaginal movement was observed for 
the patients, only few of them showed a significant loss of 
coverage. We were unable to find that rectum and bladder 
filling had significant effect on the ITV displacement or loss 
of dosimetric coverage. Vaginal ITV is a good procedure to 
ensure an acceptable dosimetric coverage. 
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Purpose/Objective: Aim of this study was to assess the role 
of whole-body 18F-fluorodeoxyglucose Positron Emission 
Tomography (18F-FDG PET) and Magnetic Resonance Imaging 
(MRI) in the management of cervical cancer. 
Materials and Methods: In pretreatment staging, 93 patients 
with histological diagnosis of cervical cancer, underwent 18F-
FDG PET in addition to routine protocol including 
International Federation of Obstetrics and Gynecology (FIGO) 
staging and MRI.  
Results: In all patients both 18F-FDG PET and MRI detected 
the primary tumor. 
In 67 patients (72%) the result of 18F-FDG PET and MRI was the 
same, but in 29 patients (31.2%) the result was different: 18F-
FDG PET detected pelvic nodal metastases not seen by MRI in 
11 cases (11.8%) and MRI detected pelvic nodal metastases 
not seen by 18F-FDG PET in 15 cases (16.1%). In 3 cases (3.2%) 
both exams was positive, but 18F-FDG PET showed a higher 
number of pelvic nodal metastases than MRI. Furthermore in 
20 cases (21.5%) 18F-FDG PET showed para-aortic nodal 
metastases. 
Conclusions: Integrating two imaging techniques allowed the 
identification of a higher number of pelvic nodal metastases, 
achieving a better initial staging and subsequent appropriate 
treatment. Finally, whole-body 18F-FDG PET was useful for 
staging extrapelvic nodal metastases.  
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Purpose/Objective: Application of conformal radiotherapy 
(CRT) with different regimes of dose fractionation in patients 
with locally advanced cervical cancer is a promising 
technique to increase the treatment effectiveness. The 
purpose of the presented work was to evaluate the efficacy 
and toxicity of the regime of accelerated fractionation during 
CRT and in vivo cytogenetic monitoring in patients with 
locally advanced cervical cancer. 
Materials and Methods: A course of combined radiotherapy 
for 37 patients with locally advanced cervical cancer treated 
on the phase I with CRT by Clinac 2100/CD linear accelerator 
with 6 MeV bremsstrahlung radiation in two regimes: 
fractionated regime of 1,3 Gy per fraction delivered twice 
daily with 4 h interval to the total focal dose of 39 Gy for the 
tumor node and 44 Gy for the pelvic lymph nodes ( group I, 
n=16) vs. standard fractionation regime of single 2,0 Gy dose 
exposure to the total focal dose of 45-46 Gy on the pelvic 
area (group II, control, n=21). In phase II of the radiotherapy 
course intracavitary brachytherapy with high-activity ??60 
source («Gyne Source») was used in the treatment of all 
patients in the regime of single 5 Gy dose exposure of the p. 
A 2 given twice daily to the total dose of 35-40 Gy/ 7-8 
fractions. Peripheral blood lymphocytes (PBL) of the cancer 
patients were the objects of cytogenetic analysis 
(chromosomal aberrations). Blood sampling in patients of 
group I was performed three times: before the CRT, and 
during the first treatment exposure; in patients of group II - 
twice: before the CRT and 24 h after first fraction.  
Results: In group I complete regression (CR) of tumors was 
registered in 21,4%, partial tumor regression (PR) - in 50,0%, 
stabilization process - in 28,6% of patients; in group II 
(control) it was 18,3%, 42,1% and 39,6% of patients with 
locally advanced cervical cancer, respectively. 
Analysis of the in vivo release of radiation markers in PBL of 
CC patients showed that accumulation rate of dicentric and 
ring chromosomes after the first treatment at the regime of 
dose accelerated fractionation (group I) was significantly 
lower in comparison with standard fractionation schedule 
(group II): 1,01 ± 0,05 per 100 metaphases after the first 
fraction of 1,3 Gy, 1,9 ± 0,15 per 100 metaphases after total 
daily dose of 2,6 Gy and 2,6 ± 0,1 per 100 metaphases 
analyzed, respectively.  
Conclusions: Analysis of the direct efficacy and toxicity of 
the treatment of the patients with locally advanced cervical 
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cancer shows the effectiveness and the absence of excess 
toxicity (above the level II) after the CRT with accelerated 
fractionation dose in CBT. It is assumed to analyze the 
dynamics of accumulation of cytogenetic markers in PBL and 
their deviation from the normal distribution in the course and 
after the CRT of cancer patients. 
   
PO-0755   
Organ shape variations influencing PTV concepts for cervix 
cancer ART 
Y. Seppenwoolde1, P. Georg1, D. Georg1, K. Bauer1, K. Moser1, 
R. Pötter1, M. Stock1 
1Medizinische Universität Wien Medical University of Vienna, 
Radiation Oncology, Vienna, Austria  
 
Purpose/Objective: Adaptive radiotherapy approaches for 
cervical cancer patients can have different levels of update 
frequency, varying between re-planning halfway along the 
treatment, weekly re-planning and plan of the day 
approaches. We investigated the variation in organ shape 
within a treatment week and the exemplarity of different 
adaptive strategies.  
Materials and Methods: For 8 cervical cancer patients we 
obtained weekly CT scans and daily CBCT scans. The primary 
and nodal GTVs, bladder, rectum, sigmoid, bowelbag were 
delineated in all 215 scans by a radiation oncologist. Six 
patients were classified as mover (>2.5 cm top of uterus 
motion), two as non-mover. In order to assess the 
appropriateness of different adapted PTV concepts, the 
volume of the cervix-uterus CTV that exceed those PTVs was 
calculated for a static PTV based on planning scan, a weekly 
update of the PTV based on weekly CT scan, a PTV of the CT 
scan with a similar bladder filling status, and based on a plan 
of the day (PotD) approach that consists of an empty – half 
full PTV and a half full – full PTV.  
Results: For the commonly used planning strategy that uses 
one planning CT scan with arbitrary bladder volume, up to 
40% of the daily CTV can be outside the PTV during one or 
more fractions of the treatment; for movers with a large 
bladder filling variation, on average 20-25%. Adaptation of 
the PTV by re-planning on a weekly CT scan, or re-planning 
based on a CT scan with similar bladder volume, decreased 
the volume of the daily CTV outside the PTV somewhat 
(Figure). Besides bladder filling also the status of the rectum 
influenced the position. A PTV created with a PotD approach, 
resulted in acceptable small volumes outside the PTV 
(average 2%). For three mover patients the uterus flipped 
backwards for a few days during treatment and a non-mover 
changed into a mover for a few fractions.  
 
Conclusions: We found that re-planning based on weekly 
imaging, although this gives a good idea about organ position 
variability and tumor shrinkage, is not sufficient to reflect 
the full extent of internal organ motion because the patient 
changes daily and often weekly scans are not made at the 
same time point (and organ configuration) as the treatment 
fraction itself. Furthermore, bladder volume-dependent 
cervix-uterus motion models that were prepared in the 
planning phase should be monitored carefully throughout the 
treatment because they can change.  
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Purpose/Objective: To compare the effect of photon and 
carbon-ion radiation on four cell lines with different HPV-
status regarding cell cycle regulation and HPV associated 
protein expression. Hypothesis is that carbon ion radiation 
might overcome radiation resistance of HPV-negative cells or 
cells with integrated HPV. 
Materials and Methods: W12 cell line was derived from a low 
grade cervical lesion by Stanley MA et al. 1989, and is unique 
among HPV16-containing cell lines in carrying its HPV 16 
genome as a multicopy episome. W12 cells contain episomal 
HPV 16 genomes, whereas S12 cells, which derived from the 
W12 line, contain HPV DNA as integrated copies. Caski cells 
have their origin in epidermoid cell cervical cancer and are 
reported to contain an HPV 16 genome as well as sequences 
related to HPV-18. C33A is a HPV-negative human cervical 
cancer derived cell line. Cell cycle analyses were performed 
using flow cytometry (PI staining) 24 h and 48 h after RT with 
2 and 7 Gy using photon RT and 2 GyE and 7 GyE carbon ion 
RT(C12). Expression of pRb and p53 after irradiation with 2 
and 7 Gy were analyzed by flow cytometry using intracellular 
staining comparing the mean fluorescence of 10000 gated 
cells. 
Results: C33A cells (HPV-negative) showed a minimal 
enhanced expression of pRB after RT with photons or C12 (0 
Gy=1.0, 2 Gy=1.09, 7 Gy=1. 4, 2 GyE= 1.3, 7 GyE=1.1). There 
was no effect of photon or C12 irradiation on p53 expression 
in C33A cells. Caski cells (HPV16/18 positive) showed 
increased expression of pRb after photon RT (2 Gy=1.3, 7 
